10.1371/journal.pone.0219142.t003
Yehuda Z. Cohen
Yehuda Z.
Cohen
Allison L. Butler
Allison L.
Butler
Katrina Millard
Katrina
Millard
Maggi Witmer-Pack
Maggi
Witmer-Pack
Rebeka Levin
Rebeka
Levin
Cecilia Unson-O’Brien
Cecilia
Unson-O’Brien
Roshni Patel
Roshni
Patel
Irina Shimeliovich
Irina
Shimeliovich
Julio C. C. Lorenzi
Julio C. C.
Lorenzi
Jill Horowitz
Jill
Horowitz
Stephen R. Walsh
Stephen R.
Walsh
Shu Lin
Shu
Lin
Joshua A. Weiner
Joshua A.
Weiner
Anna Tse
Anna
Tse
Alicia Sato
Alicia
Sato
Chelsey Bennett
Chelsey
Bennett
Bryan Mayer
Bryan
Mayer
Kelly E. Seaton
Kelly E.
Seaton
Nicole L. Yates
Nicole L.
Yates
Lindsey R. Baden
Lindsey R.
Baden
Allan C. deCamp
Allan C.
deCamp
Margaret E. Ackerman
Margaret E.
Ackerman
Michael S. Seaman
Michael S.
Seaman
Georgia D. Tomaras
Georgia D.
Tomaras
Michel C. Nussenzweig
Michel C.
Nussenzweig
Marina Caskey
Marina
Caskey
Pharmacokinetic parameters of 3BNC117 and 10–1074 administered in combination.
Public Library of Science
2019
3 BNC 117
combination
antibodies 3 BNC 117
number NCT 02824536. Findings
target non-overlapping epitopes
phase 1 study
Anti-drug antibody responses
infusion
phase 1 study Background
neutralizing anti-HIV
pre-exposure prophylaxis
2019-08-08 17:33:45
Dataset
https://plos.figshare.com/articles/dataset/Pharmacokinetic_parameters_of_3BNC117_and_10_1074_administered_in_combination_/9391604
<p>Pharmacokinetic parameters of 3BNC117 and 10–1074 administered in combination.</p>